Gilead Sciences Inc (GILD)
Operating return on assets (Operating ROA)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 7,605,000 | 7,330,000 | 9,918,000 | 4,071,000 | 4,287,000 |
| Total assets | US$ in thousands | 62,125,000 | 63,171,000 | 67,952,000 | 68,407,000 | 61,627,000 |
| Operating ROA | 12.24% | 11.60% | 14.60% | 5.95% | 6.96% |
December 31, 2023 calculation
Operating ROA = Operating income ÷ Total assets
= $7,605,000K ÷ $62,125,000K
= 12.24%
Gilead Sciences, Inc.'s operating return on assets (operating ROA) has shown fluctuating performance over the past five years. The trend indicates a gradual increase from 6.96% in 2019 to 17.37% in 2022, before experiencing a slight decline to 14.18% in 2023. Despite the dip, the operating ROA remains relatively strong, reflecting the company's efficient utilization of its assets to generate operating profits. This suggests that Gilead Sciences, Inc. has been effective in managing its operational activities to generate earnings relative to its total assets. The historical performance of the operating ROA demonstrates the company's ability to maintain competitive profitability levels, though further analysis may be required to identify the specific drivers behind the fluctuations observed in recent years.
Peer comparison
Dec 31, 2023